Highlights
- Columbia’s new BRIDGE biobank will store up to 12 million samples, enhancing access and accelerating disease research.
- Advanced BioStore system will preserve biospecimens at -80°C, ensuring sample stability and long-term usability for studies.
- Emphasis on diverse patient engagement, aiming to reduce health disparities and increase equity in medical research outcomes.
In a significant step forward for biomedical research, Columbia University’s Irving Medical Center recently unveiled its new Biobank Resource for Investigating Disease, Genes, and Environment (BRIDGE) facility. The state-of-the-art center, set to house up to 12 million patient samples, marks a major leap from the university’s previous biobank collections, which were often disease-specific. This centralized resource promises to accelerate medical discoveries by making these valuable biospecimens widely available to researchers.
BRIDGE, which received an $8 million NIH grant, will feature cutting-edge storage systems, including an automated BioStore Storage System capable of preserving samples at temperatures as low as -80°C. This ensures the long-term stability of biological materials critical to modern research. Additionally, the integration of patient electronic health records with biospecimens will give researchers enhanced access to data, facilitating more precise studies.
Columbia’s commitment to diversity is central to the biobank’s success. The facility serves patients from one of the most racially and socioeconomically diverse populations in the U.S. A dedicated community advisory board guides the biobank’s priorities, which include reducing health disparities and enhancing health equity.
The centralized facility is poised to become an invaluable resource, especially for early-career researchers. With easier access to samples and data, these investigators can fast-track their research, significantly shortening the time required to gather data. BRIDGE also offers the unique ability to collect serial samples from patients, enabling the study of disease progression over time—a vital tool for understanding and eventually intervening in chronic conditions.
As Columbia’s BRIDGE facility continues to grow, its impact on biomedical research will be far-reaching, providing a robust platform for groundbreaking discoveries and ensuring the long-term availability of critical biospecimens for decades to come.
About the Author
Biobanking.com delivers valuable news and information on biobanking, biorepositories, cryopreservation, and biosample/biospecimen management, while connects buyers with top vendors globally.
